{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:22:53Z","timestamp":1707524573655},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"DOI":"10.7759\/cureus.26794","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T01:50:05Z","timestamp":1657677005000},"source":"Crossref","is-referenced-by-count":0,"title":["Primary Effusion Lymphoma Presenting As Parapneumonic Pleural Effusion"],"prefix":"10.7759","author":[{"given":"Rahul","family":"Gujarathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narsimha","family":"Candula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venu","family":"Chippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meet","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alkhasawneh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Primary effusion lymphoma","author":"Said J","year":"2008","unstructured":"Said J, Cesarman E, Harris NL. Primary effusion lymphoma. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH (ed): IARC Press, Lyon, France; 2008. 260-1."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.14.1880","article-title":"HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis","volume":"285","author":"Little RF","year":"2001","unstructured":"Little RF, Gutierrez M, Jaffe ES, Pau A, Horne M, Wilson W. HIV-associated non-Hodgkin lymphoma: incidence, presentation, and prognosis. JAMA. 2001, 285:1880-5. 10.1001\/jama.285.14.1880","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-569","article-title":"Primary effusion lymphoma","volume":"12","author":"Chen YB","year":"2007","unstructured":"Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007, 12:569-76. 10.1634\/theoncologist.12-5-569","journal-title":"Oncologist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.013","article-title":"Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study","volume":"21","author":"Simonelli C","year":"2003","unstructured":"Simonelli C, Spina M, Cinelli R, et al.. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol. 2003, 21:3948-54. 10.1200\/JCO.2003.06.013","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.20-2-s53","article-title":"Primary effusion lymphoma (PEL) in a renal transplant patient","volume":"20","author":"Noureldin R","year":"2020","unstructured":"Noureldin R, Athar S, Nagrale V, Gaba W. Primary effusion lymphoma (PEL) in a renal transplant patient. Clin Med (Lond). 2020, 20:s53-4. 10.7861\/clinmed.20-2-s53","journal-title":"Clin Med (Lond)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199808133390705","article-title":"Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient","volume":"339","author":"Jones D","year":"1998","unstructured":"Jones D, Ballestas ME, Kaye KM, et al.. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med. 1998, 339:444-9. 10.1056\/NEJM199808133390705","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401390","article-title":"Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8","volume":"13","author":"Dotti","year":"1999","unstructured":"Dotti, G., Fiocchi, et al.. Primary effusion lymphoma after heart transplantation: a new entity associated with human herpesvirus-8. Leukemia. 1999, 13:664-70. 10.1038\/sj.leu.2401390","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02156.x","article-title":"Pleural primary effusion lymphoma in a renal transplant recipient","volume":"8","author":"Melo NC","year":"2008","unstructured":"Melo NC, Sales MM, Santana AN, Costalonga EC, Pedreira AB, Ianhez LE. Pleural primary effusion lymphoma in a renal transplant recipient. Am J Transplant. 2008, 8:906-7. 10.1111\/j.1600-6143.2008.02156.x","journal-title":"Am J Transplant"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10112638","article-title":"Pleural disease and acquired immune deficiency syndrome","volume":"10","author":"Light RW","year":"1997","unstructured":"Light RW, Hamm H. Pleural disease and acquired immune deficiency syndrome. Eur Respir J. 1997, 10:2638-43. 10.1183\/09031936.97.10112638","journal-title":"Eur Respir J"},{"key":"ref10","unstructured":"https.\/\/doi.org\/10.1182\/blood-2018-03-791426."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-05-092288","article-title":"The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells","volume":"111","author":"Wies E","year":"2008","unstructured":"Wies E, Mori Y, Hahn A, Kremmer E, St\u00fcrzl M, Fleckenstein B, Neipel F. The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells. Blood. 2008, 111:320-7. 10.1182\/blood-2007-05-092288","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06879.x","article-title":"KSHV\/HHV8-associated lymphomas","volume":"140","author":"Carbone A","year":"2008","unstructured":"Carbone A, Gloghini A. KSHV\/HHV8-associated lymphomas. Br J Haematol. 2008, 140:13-24. 10.1111\/j.1365-2141.2007.06879.x","journal-title":"Br J Haematol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.047969","article-title":"Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8 and lymphoproliferative disorders","volume":"60","author":"Du MQ","year":"2007","unstructured":"Du MQ, Bacon CM, Isaacson PG. Kaposi sarcoma-associated herpesvirus\/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol. 2007, 60:1350-7. 10.1136\/jcp.2007.047969","journal-title":"J Clin Pathol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"15","author":"Nador RG","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A, et al.. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996, 15:645-56. 10.1182\/blood.V88.2.645.bloodjournal882645","journal-title":"Blood"},{"key":"ref15","article-title":"Primary cavity-based lymphoma and HIV infection (Article in Spanish)","volume":"199","author":"Ortega MEV","year":"1999","unstructured":"Ortega MEV, Santos PM, Aguado FG, Quintana FB, Cuesta FL, V\u00e1zquez VS, Lahoz JG. Primary cavity-based lymphoma and HIV infection (Article in Spanish). Rev Clin Esp. 1999, 199:73-7.","journal-title":"Rev Clin Esp"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn A","year":"2004","unstructured":"Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol. 2004, 28:1401-16. 10.1097\/01.pas.0000138177.10829.5c","journal-title":"Am J Surg Pathol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2007.051953","article-title":"HIV infection and lymphoma","volume":"60","author":"Grogg KL","year":"2007","unstructured":"Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007, 60:1365-72. 10.1136\/jcp.2007.051953","journal-title":"J Clin Pathol"},{"key":"ref18","article-title":"Primary effusion lymphoma","author":"Banks PM","year":"2001","unstructured":"Banks PM, Warnke RA. Primary effusion lymphoma. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW (ed): IARC Press, Lyon, France; 2001. 179."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199803)57:3<266::AID-AJH25>3.0.CO;2-7","article-title":"Complete remission of a primary effusion lymphoma with antiretroviral therapy","volume":"10","author":"Oksenhendler E","year":"1998","unstructured":"Oksenhendler E, Clauvel JP, Jouveshomme S, et al.. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol. 1998, 10:25-3. 10.1002\/(SICI)1096-8652(199803)57:3&lt;266::AID-AJH25&gt;3.0.CO;2-7","journal-title":"Am J Hematol"},{"key":"ref20","article-title":"The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions","volume":"1","author":"Komanduri KV","year":"1996","unstructured":"Komanduri KV, Luce JA, McGrath MS, et al.. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 1:215-26.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.926433","article-title":"A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-Iris) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review","volume":"21","author":"Dumic I","year":"2020","unstructured":"Dumic I, Radovanovic M, Igandan O, et al.. A fatal case of Kaposi sarcoma immune reconstitution syndrome (KS-Iris) complicated by Kaposi sarcoma inflammatory cytokine syndrome (KICS) or multicentric Castleman disease (MCD): a case report and review. Am J Case Rep. 2020, 21:e926433. 10.12659\/AJCR.926433","journal-title":"Am J Case Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(97)90153-2","article-title":"Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm","volume":"28","author":"Karcher DS","year":"1997","unstructured":"Karcher DS, Alkan S. Human herpesvirus-8-associated body cavity-based lymphoma in human immunodeficiency virus-infected patients: a unique B-cell neoplasm. Hum Pathol. 1997, 28:801-8. 10.1016\/S0046-8177(97)90153-2","journal-title":"Hum Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10341","article-title":"Combined chemotherapy including high-dose methotrexate in KSHV\/HHV8-associated primary effusion lymphoma","volume":"73","author":"Boulanger E","year":"2003","unstructured":"Boulanger E, Daniel MT, Agbalika F, Oksenhendler E. Combined chemotherapy including high-dose methotrexate in KSHV\/HHV8-associated primary effusion lymphoma. Am J Hematol. 2003, 73:143-8. 10.1002\/ajh.10341","journal-title":"Am J Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2019.03.021","article-title":"High-dose therapy and autologous hematopoietic cell transplantation as consolidation treatment for primary effusion lymphoma","volume":"19","author":"Mirza AS","year":"2019","unstructured":"Mirza AS, Dholaria BR, Hussaini M, et al.. High-dose therapy and autologous hematopoietic cell transplantation as consolidation treatment for primary effusion lymphoma. Clin Lymphoma Myeloma Leuk. 2019, 19:e513-20. 10.1016\/j.clml.2019.03.021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.18.3350","article-title":"Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma","volume":"26","author":"Cassoni A","year":"2008","unstructured":"Cassoni A, Ali U, Cave J, Edwards SG, Ramsay A, Miller RF, Lee SM. Remission after radiotherapy for a patient with chemotherapy-refractory HIV-associated primary effusion lymphoma. J Clin Oncol. 2008, 26:5297-9. 10.1200\/JCO.2008.18.3350","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/84597-primary-effusion-lymphoma-presenting-as-parapneumonic-pleural-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:42Z","timestamp":1707507582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/84597-primary-effusion-lymphoma-presenting-as-parapneumonic-pleural-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,12]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.26794","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,12]]}}}